ABCG2 and cancer: Furthermore, numerous in vitro and in vivo studies indicate that the inhibition of the efflux function and/or expression of the ABCB1 or ABCG2 transporter can significantly increase the efficacy of certain anticancer drugs in various types of cancers that overexpress these ABC transporters [19].